新锐医药国际控股有限公司（股票代码：06108）于2026年6月2日发布截至2026年5月31日的月度股份变动报告。报告显示，该公司本月授权及已发行股本均未发生变化，股本结构持续保持稳定。
根据公告，公司的法定/注册股本为15,000,000,000股普通股，每股面值0.01港元，注册股本合计1.50亿港元。截至2026年5月31日，已发行股份总数为200,616,665股，与上月持平，未出现新增发行、购回或注销股票的情况，亦未有库藏股变动。
在股权激励方面，公司于2013年通过的购股权计划下，尚余12,820,000份购股权，截至报告期内并未因行使或回购产生股份变动，期权余额保持不变。
公司确认已遵守香港联合交易所有限公司的相关上市规则及适用的法律规定。公告由公司秘书吴日升签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.